LICENSE GREEMENTLicense Agreement • May 10th, 2013 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This LICENSE AGREEMENT (the "Agreement") is made this 1st day of September, 2012 (the "Effective Date"), by and between FUJIFILM RI Pharma Co., Ltd., (FRI) having its principal place of business at 14-1, Kyobashi 2-Chome, Chuo-Ku, Tokyo, 104-0031 Japan, and Molecular Insight Pharmaceuticals, Inc. (MIP) having its principal place of business at 160 Second Street, Cambridge, Massachusetts, USA; each a "Party" to this Agreement and collectively the "Parties".
STOCK PURCHASE AND SALE AGREEMENT BY AND BETWEEN THE STOCKHOLDERS OF MOLECULAR INSIGHT PHARMACEUTICALS, INC. (THE "STOCKHOLDERS") MOLECULAR INSIGHT PHARMACEUTICALS, INC. (THE "COMPANY") PROGENICS PHARMACEUTICALS, INC. (THE "BUYER") AND HIGHLAND...Stock Purchase and Sale Agreement • May 10th, 2013 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS STOCK PURCHASE AND SALE AGREEMENT is made and entered into as of January 16, 2013 (the "Effective Date"), by and among each of the Stockholders listed on Schedule A attached hereto (each individually, a "Stockholder" and collectively, the "Stockholders"), Molecular Insight Pharmaceuticals, Inc., a Delaware corporation duly organized under law (the "Company"), Progenics Pharmaceuticals, Inc., a Delaware corporation duly organized under law (the "Buyer"), and Highland Capital Management, L.P., as stockholders' representative (the "Stockholders Representative"). The Buyer, Company, the Stockholders Representative and Stockholders are sometimes individually referred to as a "Party", and collectively, as the "Parties".
